Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma Of Esophagus × durvalumab × Clear all

Phase

Status

Recruiting 2 Active not recruiting 2 Withdrawn 1 Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 13 Small Cell Lung Carcinoma 8 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Lung Neoplasms 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Rectal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Biliary Tract Neoplasms 3 Stomach Neoplasms 2 Recurrence 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Lymphoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Merkel Cell 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Unresectable Stage III NSCLC 1 Triple Negative Breast Neoplasms 1 Resectable Biliary Tract Cancer 1 Platinum-resistant Recurrent Ovarian Cancer 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Radiotherapy 3 Fluorouracil 3 Endoscopy, Digestive System 3 Endoscopy 3 Paclitaxel 2 Leucovorin 2 Endoscopic Mucosal Resection 2 Cryotherapy 2 Cisplatin 2 Cetuximab 2 tremelimumab 1 rucaparib 1 rubitecan 1 durvalumab 1 Taxes 1 Surveys and Questionnaires 1 Spectrum Analysis 1 Ramucirumab 1 Radiation 1 Positron Emission Tomography Computed Tomography 1 Oxaliplatin 1 Nivolumab 1 Microarray Analysis 1 Magnetic Resonance Imaging 1 Irinotecan 1 High-Throughput Screening Assays 1 Genetic Linkage 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04159974 2024-05-09

RICE

University of Cologne

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡